Abstract

Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and PlasmaMolecular & Cellular ProteomicsVol. 17Issue 11PreviewGlioblastoma multiforme (GBM) is the most aggressive brain tumor with poor prognosis to most patients. Immunotherapy of GBM is a potentially beneficial treatment option, whose optimal implementation may depend on familiarity with tumor specific antigens, presented as HLA peptides by the GBM cells. Furthermore, early detection of GBM, such as by a routine blood test, may improve survival, even with the current treatment modalities. This study includes large-scale analyses of the HLA peptidome (immunopeptidome) of the plasma-soluble HLA molecules (sHLA) of 142 plasma samples, and the membranal HLA of GBM tumors of 10 of these patients' tumor samples. Full-Text PDF Open Access VOLUME 17 (2018) PAGES 2132–2145 The original version of this article was withdrawn by the authors. An error was discovered in the creation of the protein database file that was used for searching, which led to some incorrect associations between peptides and proteins. A corrected version of the manuscript has been supplied which contains the very similar peptide identifications as the original, but the resulting number of proteins in various categories has now changed, and as a result some of the figures and supplementary files have changed also. The underlying conclusions of this study, however, remain unaltered. The corrected version can be accessed (Shraibman, B., Barnea, E., Kadosh, D. M., Haimovich, Y., Slobodin, G., Rosner, I., López-Larrea, C., Hilf, N., Kuttruff, S., Song, C., Britten, C., Castle, J., Kreiter, S., Frenzel, K., Tatagiba, M., Tabatabai, G., Dietrich, P.-Y., Dutoit, V., Wick, W., Platten, M., Winkler, F., von Deimling, A., Kroep, J., Sahuquillo, J., Martinez-Ricarte, F., Rodon, J., Lassen, U., Ottensmeier, C., van der Burg, S. H., Thor Straten, P., Poulsen, H. S., Ponsati, B., Okada, H., Rammensee, H. G., Sahin, U., Singh, H., and Admon, A. (2019) Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma. Mol. Cell. Proteomics 18, 1255–1268).

Highlights

  • The original version of this article was withdrawn by the authors

  • An error was discovered in the creation of the protein database file that was used for searching, which led to some incorrect associations between peptides and proteins

  • (2019) Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma

Read more

Summary

Introduction

Withdrawal: Identification of tumor antigens among the HLA peptidomes of glioblastoma tumors and plasma. The original version of this article was withdrawn by the authors.

Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call